PPADS inhibits P2Y1 purinoceptors in rat brain capillary endothelial cells and in rat ileal myocytes by an indirect mechanism

Biochemical and Biophysical Research Communications

Volumn 244, Issue 2, 1998, Pages 332-335

  Vigne, Paul ^a   Pacaud, Pierre ^a   Loirand, Gervaise ^a   Breittmayer, Jean Philippe ^b   Frelin, Christian ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; CALCIUM; PURINE P2Y RECEPTOR; RECEPTOR SUBTYPE; SULFONIC ACID DERIVATIVE; DRUG DERIVATIVE; PURINE P2 RECEPTOR; PURINE P2Y1 RECEPTOR; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID;

ANIMAL CELL; ARTICLE; BRAIN CAPILLARY; CALCIUM CELL LEVEL; ENDOTHELIUM CELL; MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BRAIN; CELL CLONE; DRUG ANTAGONISM; DRUG EFFECT; ILEUM; IN VITRO STUDY; INTRACELLULAR FLUID; KINETICS; METABOLISM; SMOOTH MUSCLE; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALIA;

ADENOSINE DIPHOSPHATE; ANIMALS; BRAIN; CALCIUM; CLONE CELLS; ENDOTHELIUM, VASCULAR; ILEUM; INTRACELLULAR FLUID; KINETICS; MUSCLE, SMOOTH; PYRIDOXAL PHOSPHATE; RATS; RECEPTORS, PURINERGIC P2;

EID: 0032539717     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.1998.8262     Document Type: Article

References (17)

1. Abbracchio M. P., Burnstock G. Pharmac. Ther. 64:1994;445-475.
2. Dubyak G. R., El-Moatassim C. Am. J. Physiol. 265:1993;C577-C606.
3. Harden T. K., Boyer J. L., Nicholas R. A. Annu. Rev. Pharmacol. Toxicol. 35:1995;541-579.
4. Webb T. E., Simon J., Krishek B. J., Bateson A. N., Smart T. G., King B. F., Burnstock G., Barnard E. A. FEBS Letters. 324:1993;219-225.
5. Filtz T. M., Li Q., Boyer J. L., Nicholas R. A., Harden T. K. Mol. Pharmacol. 46:1994;8-14.
6. Henderson D. J., Elliot D. G., Smith G. M., Webb T. E., Dainty I. A. Biochem. Biophys. Res. Comm. 212:1995;648-656.
7. Tokuyama Y., Hara M., Jones E. M. C., Fan Z., Bell G. I. Biochem. Biophys. Res. Comm. 211:1995;211-218.
8. Ayyanathan K., Webb T. E., Sandhu A. K., Athwal R. S., Barnard E. A., Kanapuli S. P. Biochem. Biophys. Res. Comm. 218:1996;783-788.
9. Schachter J. B., Li Q., Boyer J. L., Nicholas R. A., Harden T. K. Br. J. Pharmacol. 118:1996;167-173.
10. Schachter J. B., Harden T. K. Br. J. Pharmacol. 121:1997;338-344.
11. Webb T. E., Feolde E., Vigne P., Neary J. T., Runberg A., Frelin C., Barnard E. Br. J. Pharmacol. 119:1996;1385-1392.
12. Pacaud P., Feolde E., Frelin C., Loirand G. Br. J. Pharmacol. 118:1996;2213-2219.
13. Feolde E., Vigne P., Breittmayer J. P., Frelin C. Br. J. Pharmacol. 115:1995;1199-1203.
14. Vigne P., Feolde E., Breittmayer J. P., Frelin C. Br. J. Pharmacol. 112:1994;775-780.
15. Pacaud P., Bolton T. B. J. Physiol. 441:1991;477-499.
16. Buell G., Lewis C., Collo G., North R. A., Surprenant A. EMBO J. 15:1996;55-62.
17. Vigne P., Pacaud P., Urbach V., Feolde E., Breittmayer J. P., Frelin C. Br. J. Pharmacol. 119:1996;360-364.